Dr. Campbell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
621 North Hall Street, Suite 500
Dallas, TX 75226Phone+1 469-800-7400
Summary
- Courtney M. Campbell, MD, PhD is a cardiologist at Cardiology Consultants of Texas and the Medical Director of Cardiology-Oncology at Baylor Scott and White Heart and Vascular Hospital, Dallas. She is an expert in the cardiovascular care of oncology patients and in patients with amyloidosis.
Cardio-Oncology includes cardiovascular care prior to cancer therapy, during cancer therapy, and throughout cancer survivorship. The discipline focuses on cardiovascular optimization, cardiac monitoring, and preventive cardiovascular care throughout the cancer spectrum. In addition, cardio-oncology aims to minimize disruption in cancer therapy through management of short- and long-term cancer-treated related cardiotoxicity and treatment of acute cardiac issues. Cardio-Oncology is a highly dynamic field as cancer and amyloidosis therapy rapidly evolves.
Within the Cardiology-Oncology program, we seek to bring the latest advances and approaches to our patients to improve their quality of life via excellent patient care, engagement in clinical trials, and robust clinical-translational research collaborations. As a physician-scientist, Dr. Campbell's research interests are in early diagnostic approaches and intervention in cardio-oncology and amyloidosis through prospective studies, clinical trials, and multidisciplinary collaboration.
Dr. Campbell was born and raised in Dallas, Texas. She studied History of Science at Harvard University, completing bachelor’s and master’s degrees. She earned her MD and PhD in Pharmacology from Vanderbilt University. As part of the Physician Scientist Training Program, she completed her internal medicine residency and cardiovascular medicine fellowship at The Ohio State University. She then completed additional fellowship training in Cardio-Oncology and Amyloidosis at Washington University in St. Louis and served as an attending (supervising) physician. She is thrilled to be home now in Dallas, serving the community she grew up in.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Cardio-Oncology and Amyloidosis, 2021 - 2022
- Ohio State University HospitalFellowship, Cardiovascular Disease, 2017 - 2021
- Ohio State University HospitalResidency, Internal Medicine, 2015 - 2017
- Vanderbilt University School of MedicineClass of 2015
- Vanderbilt University Graduate SchoolPhD, Pharmacology, 2007 - 2013
- Harvard UniversityMA, History of Science, 2005 - 2006
- Harvard UniversityBA, History of Science, Cum Laude, 2002 - 2006
Certifications & Licensure
- TX State Medical License 2022 - 2026
- MO State Medical License 2021 - 2025
- OH State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- International Cardio-Oncology Society Board Certification in Cardio-Oncology
Publications & Presentations
PubMed
- 23 citationsCardiovascular Toxicities of Androgen Deprivation Therapy.Azariyas A. Challa, Adam C. Calaway, Jennifer Cullen, Jorge A. Garcia, Nihar R. Desai
Current Treatment Options in Oncology. 2021-04-17 - 22 citationsSelective targeting of gain-of-function KCNQ1 mutations predisposing to atrial fibrillationCourtney M. Campbell, Jonathan D. Campbell, Christopher H. Thompson, Eleonora Savio Galimberti, Dawood Darbar
Circulation. Arrhythmia and Electrophysiology. 2013-10-01 - 2 citationsDelayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support.Tarun Ramayya, Joshua D Mitchell, Justin C Hartupee, Kory Lavine, Clare H Ridley
JACC. Cardiooncology. 2022-12-01
Abstracts/Posters
- Initiation of Cardiology Care in Cardiac Amyloidosis: A Single Center ExperienceCampbell CM, Mbeng CA, Rodgers B, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Kahwash R, Vallakati A, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
- Orthopaedics History Preceding Diagnosis of Cardiac Amyloidosis: Timing and Variation by SubtypeCampbell CM, Mbeng CA, Rodgers B, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallaka..., International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
- High price and US insurance practices delay and limit access to Tafamidis for patients with transthyretin cardiac amyloidosis: A Single Center Experience.Campbell CM, Bumma N, Efebera Y, Sharma N, Parikh S, Almaani S, Prosek J, Bittengle J, Pfund K, LoRusso S, Freimer M, Redder E, Kahwash R, Vallkati A, International Symposium on Amyloidosis, Tarragona, Spain, 9/2020
- Join now to see all
Press Mentions
- Long Delays in Amyloidosis Dx, Even With Established Cardiac CareJune 30th, 2020
- ACC Cardio-Oncology Course Drives Discourse, Innovation in Fast-Growing FieldOctober 16th, 2020
Professional Memberships
- Member
- Member
- International Cardio-Oncology SocietyMember
- International Society of AmyloidosisMember
External Links
- My bibliographyhttps://www.ncbi.nlm.nih.gov/myncbi/1pWww-vUdydAb/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: